A beginner's guide to immunotherapy
10am - 12.30pmVirtual, online
Format: This is a live, virtual event. The content is split over three sessions of 30-40 minutes each. Elaine will be online throughout to interact with learners and answer questions in the live Q&A sessions that follow each presentation. Recordings of the presentations will be available online for 30 days after the live event.
Description: Elaine describes cancer’s relationship with the immune system and the science behind many different types of immunotherapy. Treatments covered include checkpoint inhibitors (e.g. ipilimumab, pembrolizumab, nivolumab), cell-based treatments (CAR T cell therapy, TCR-engineered T cells), and vaccine-based treatments (peptide, dendritic cell, oncolytic viruses).
Audience: Ideal for anyone with an A level or equivalent understanding of cell biology and genetics and who works with cancer patients, data or treatments.